Speaker information will be added as speakers are confirmed. Please check this page regularly for updated information. Click on the letter below to navigate by speaker’s last name.    

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gerardo Cajaraville, Former Head of Pharmacy Department, Onkologikoa Hospital, San Sebastián, Spain  

Pharmacy Degree. Navarra University (1979), Residence program in Hospital Pharmacy at Pharmacy Department of “Clinica Universitaria de Navarra” (1980-1983), Hospital Pharmacist Specialist (1984) 
Head of Pharmacy Department at Onkologikoa Hospital from 1985 to 2021 and Director of Quality Management and Information Technologies and member of steering Committee from 2013 to 2020 
Associate Professor, Faculty of Pharmacy, University of Navarra from 2001 to 2013.
Founder and Chairman of Spanish Group of Oncology Pharmacists (GEDEFO) from 1995 to 2014 
Joaquin bonal medal awarded by SEFH in 2016.
He has extensive experience in Oncology Pharmacy with multiple Conferences, publications and R+D+i projects with competitive grants. 

Carole Chambers, Director, Cancer Services, AHS Pharmacy, Calgary, Alberta, Canada 

Carole Chambers is the Pharmacy Director Cancer Services, Alberta Health Services, with over 85 peer reviewed publications. She served on the Board of the Institute for Safe Medication Practice (ISMP-Canada) from 2014 to 2021. In Canada she holds Fellowship status with both the CSHP and CaPHO.  In ISOPP Carole served as ISOPP President (2006 -10) and is currently a member of the JOPP Editorial Board and ISOPP Virtual Journal Club. She holds an ISOPP Fellowship as well as the Helen McKinnon award recognizing her significant contribution to ISOPP and oncology pharmacy practice.

Associate Professor Lita Chew, Head of Pharmacy Department, National Cancer Center Singapore, Singapore 

Associate Professor Lita Chew received her pharmacy degree from Singapore and obtained her post-graduate masters in medical science at University of Birmingham, United Kingdom. She completed her fellowship training in Pharmacy Practice at the University Illinois Chicago, USA.  An inspiring Pharmacy leader with more than 30 years of practice experience in oncology pharmacy, A/P Chew’s work impacts pharmacy practice and pharmacy workforce in Singapore. She holds concurrent positions as the Group Director for Allied Health at Singhealth, Head of Pharmacy Department at the National Cancer Centre Singapore, faculty member at National University of Singapore, and Senior Advisor for Chief Pharmacist’s Office at Ministry of Health Singapore.

Roberto Collado-Borrell, PharmD, PhD. Hospital General Universitario Gregorio Marañón, Madrid, Spain

Roberto Collado is an Oncology Pharmacist at the Gregorio Marañón University Hospital. He has been working in the field of Oncology Pharmacy for over 10 years.
 

David Conde-Estévez, PharmD PhD, BCOP, Oncology Clinical Pharmacist, Hospital del Mar, Barcelona, Spain

David Conde-Estévez is an Oncology Clinical Pharmacist at Hospital del Mar of Barcelona, Spain. He graduated in 2002 as a Pharmacist from the University of Barcelona and in 2005 as a Biochemist, also at the University of Barcelona. After 4 years as a Pharmacy Resident at Hospital del Mar de Barcelona, he started working as an Oncology Clinical Pharmacist at the same hospital in 2009. 
Since then, he has been focusing his activity in Outpatient Department, validating all kind of onco-hematological treatments as well as doing educational activities in patients treated with Oral Anticancer Drugs. He participates in different onco-hematological boards. At present time he is a researcher in the Molecular Therapy Group of the IMIM Cancer Research Programme (Hospital del Mar Research Institute).
He is a current member of the Editorial Board of "Farmacia Hospitalaria" and of the "Circular Farmaceutica" of the Official College of Pharmacists of Barcelona (COFB), as well as member of its Board as representative of the Hospital Pharmacy. 
He is associate lecturer of Medicine at Pompeu Fabra University in Barcelona (Department of Medicine and Life Sciences).

Netty Cracknell, Lead Cancer Pharmacist, Ramsay Healthcare, London, U.K.

Netty is an experienced oncology pharmacist and has worked for over 18 years in this sector. She has a vast range of experience including various lead cancer pharmacy clinical roles within government and private hospitals as well as project management positions. Netty is a Fellow of the Royal Pharmaceutical Society in the UK and is currently in a national role as the Lead Cancer Pharmacist for Ramsay Healthcare UK. 
Netty has been involved in BOPA and ISOPP for many years and is passionate about enhancing cancer care throughout the world and improving safety for patients across all continents. Over her career she has written SACT protocols for approximately 4 hospital groups and is keen to see this duplication of work reduced globally and concepts shared throughout the oncology pharmacy community. 

Melanie Danilak, BSc. Pharm, ACPR, MEd, Assessment Developer, Alberta College of Pharmacy, Canada

Melanie’s current role with the pharmacy regulatory body in Alberta is focused on program development, assessment, and evaluation.  Prior to this, she practiced clinically for many years in a breast cancer ambulatory clinic as well as in the emerging field of rheumatology-immuno-oncology.  
Melanie’s interest around sexual health in patients with cancer arose after witnessing the common issues experienced by patients in her breast cancer practice and through the opportunity to participate in a multidisciplinary course offered by the DeSouza Institute titled “Sexual Health in Cancer.”  Melanie is passionate about pharmacy education and program development. She is currently the vice-chair of the Canadian Pharmacy Residency Board and is an active ISOPP volunteer on the finance and education committees.

Paula de Juan Garcia, Hospital Oncology Pharmacist, Hospital University of Guadalajara, Guadalajara, Spain 

Paula de Juan Garcia is a Hospital Oncology Pharmacist in University Hospital of Guadalajara, certified in Oncology Pharmacy by BPS. She has been working in the area of Oncology Pharmacy for more than 20 years. She has been part of the Chemotherapy Desensitization Team since 2010, working closely with Dra Vega.

Vanessa Domínguez Leñero, Hospital Pharmacist, Hospital Morales Meseguer, Murcia, Spain 

Degree in Pharmacy from the University of Seville. PhD in Health Sciences from the Catholic University of Murcia. Specialist in Hospital Pharmacy since 2010, training period between 2006 and 2010 at the Juan Ramon Jiménez de Huelva University Hospital. From 2010 to 2013, I developed my activity as Head of Service at the Perpetuo Socorro Hospital in Cartagena. After that I had the opportunity to create the S de Farmacia del Centro Medico Milenium de Murcia to cover the oncology area and at the same time in the Hospital Comarcal La Inmaculada, Huércal Overa. Since then, I have not stopped dedicating myself to oncology pharmacy and from 2017 to the present I am an assistant in the oncology pharmacy area of the Pharmacy S of the Morales Meseguer University Hospital.

Vicente Escudero Vilaplana, Pharmacist, Hospital General Univ. Gregorio Marañón, Madrid, Spain  

Vicente is a Pharmacist, specialized in Hospital Pharmacy since 2011 and Doctor of Pharmacy since 2014. Assistance activity focused on care and pharmacotherapeutic monitoring of patients, specializing in oncohematological patients. Author of more than 60 scientific publications.

Mª Paz Espinosa Gómez, Farmacéutica Adjunta Área de Onco-hematología, Hospital Universitario de Burgos, Spain

LEA del Servicio de Farmacia 
Hospital Universitario de Burgos 
 

Eduard Fort Casamartina, Oncology Clinical Pharmacist, Catalan Institut of Oncology, Barcelona, Spain

Eduard Fort graduated in 1999 as a Pharmacist from the University of Barcelona and in 2005, as a Statics in Health Sciences by Autonomous University of Barcelona. After 4 years as a Pharmacy resident in University Bellvitge Hospital, he started to work in 2006 in Monographyc Oncohematological Hospital Duran Reynals (Catalan Institut of Oncology), as a Oncological Clinical Pharmacy in the Out-Patient Unit and Clinical Nutrition Unit. Since 2021, he had focused his activity in Out-Patient Unit doing educational program in oncohematological patients who where treated by oral anticancer drugs.

Dr. Michael Ganio Pharm.D., M.S., BCSCP, FASHP Senior Director, Pharmacy Practice and Quality, ASHP, U.S.A

Dr. Ganio joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug safety, and other practice-related topics. 
Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Sterile Compounding Pharmacist (BCSCP) and was inducted as a fellow of ASHP in 2017. 
Dr. Ganio has nearly 20 years of hospital and health-system experience. His previous job roles have included clinical pharmacy practice, pharmacy informatics and technology, and outpatient oncology pharmacy operations. He has extensive knowledge of drug shortage management, pharmacy informatics and automation, medication billing and reimbursement, sterile compounding, and outpatient infusion and ambulatory-care practice models. Dr. Ganio has been invited to speak at several national and international conferences, including several meetings at the National Academy of Medicine on topics related to drug shortages and supply-chain challenges.

Hector Carlos Garcia, Hospital Vall D´Hebron, Barcelona, Spain 

My name is Hector Carlos Garcia. I graduated in Pharmacy from the Complutense University of Madrid and I did a Master in Biomedicine specialized in translational research in cancer at the University of Barcelona. I am currently in my third year of residency in Hospital Pharmacy at the Hospital Universitari Vall d'Hebron in Barcelona. I am interested in Pharmaceutical Oncology so I have done a master's degree at the Universitat de Valencia during my residency and I try to research and publish in this area. Within this area I especially like cancers of the digestive tract and targeted therapies.

Leire García López, Hospital Universitario la Paz, Spain

Leire has a degree in Pharmacy from the University of Navarra and is currently specialising in Hospital Pharmacy at the Hospital Universitario la Paz (Madrid).

Marga Garrido, PHD, Head of Oncology Pharmacy Unit, Hospital Virgen de la Victoria de Málaga, Málaga, Spain  

Marga Garrido is PhD in Pharmacy, hospital pharmacy specialist and Board Certified Oncology Pharmacist. Since 2018 she is member of the GEDEFO coordinating group, the Oncologic Pharmacy Working Group of Sociedad Española de Farmacia Hospitalaria.
She is currently in charge of the oncology pharmacy unit at the hospital Virgen de la Victoria de Málaga (Spain).

 

Marta Gilabert Sotoca, Hospital Pharmacy Specialist, Arnau de Villanova Hospital University, Lleida, Spain

Marta is a Hospital Pharmacy Specialist. 
Pharmacist in the Oncology and Hematology Pharmacy Unit of the  Arnau de Vilanova University Hospital in Lleida since June 2017 
Participant in regional guidelines for cancer treatment 
Research collaborator of different studies of the Oncology and Hematology Pharmacy Unit 
Oral presentation abstract award nominee. EAHP Congress 2018 
Board of Pharmacy Specialties (Board Certified Oncology Pharmacist) 2021 .
Adjunct professor in Barcelona University 2022-2023 

Sarah Glewis, Clinical Pharmacogenetics Pharmacist, Peter MacCallum Cancer Centre, Melbourne, Australia

Sarah Glewis is a clinical pharmacogenetics pharmacist at Peter MacCallum Cancer Centre and a PhD student with the university of Melbourne, Australia. She is specializing in clinical Pharmacogenetics and Pharmacokinetics. Principle investigator for PACIFIC-PGx a multisite clinical trial.

She has been awarded a research grant from the ISOPP to support her Pharmacogenetics research work extending to regional areas in Australia. Her work in Pharmacogenetics has been recognized in the Victorian HealthCare Award in 2022. 

Evelyn Handel, Director of Drugs & Biologics Programs, National Comprehensive Cancer Network (NCCN), U.S.A. 

Evelyn Handel is the Director of Drugs & Biologics Programs at the National Comprehensive Cancer Network (NCCN) in Philadelphia, USA. In this role, she collaborates with a multidisciplinary team and is responsible for oversight and management of the Drugs & Biologics Programs including the NCCN Drugs & Biologics Compendium and the NCCN Chemotherapy Order Templates, which are derivative products of the NCCN Clinical Practice Guidelines in Oncology.  Additional responsibilities include partnering with licensees to integrate and ensure accurate representation of NCCN Compendium and Template information in 3rd party electronic information systems including electronic health records (EHR) and clinical decision support tools.  She also facilitates the NCCN Pharmacy Directors Forum and provides oversight for the multidisciplinary NCCN Chemotherapy Order Templates (COT) Committee. 
Prior to joining NCCN, Evelyn was an Oncology Clinical Pharmacy Specialist at Roswell Park Comprehensive Cancer Center and also worked as a Clinical Oncology Pharmacist at the University of Virginia Hospital. She previously completed a PGY1 Pharmacy Practice Residency at Oregon Health & Science University followed by a PGY2 Oncology Pharmacy Residency at the H. Lee Moffitt Cancer Center and has also achieved Board Certification as a Pharmacotherapy Specialist (BCPS) and as an Oncology Pharmacist (BCOP).

Cristina Ibáñez Collado, PharmD, BCOP, Pharmacy Service, Catalan Institute of Oncology, Barcelona, Spain

Cristina Ibáñez graduated in 2000 as a Pharmacist from the University of Barcelona. After completing a 4-year period of Hospital Pharmacy residency in the Vall d’Hebron University Hospital in Barcelona, she joined the Catalan Health Service where she developed different management tasks to promote the rational use of medicines, specially in the outpatient hospital area, but in the community area as well. 
She achieved Board Certification as an Oncology Pharmacist (BCOP) and currently she serves as a pharmacist in the Catalan Institute of Oncology, a public comprehensive cancer center in Catalonia. She is focused on anticancer drug evaluation and positioning of medicines, both at a local, regional, and national level, involved in practice guidelines development, and in the evaluation of health results. 
She is associate lecturer of Pharmacy degree at Blanquerna School of Health Sciences-Ramon Llull University in Barcelona (Spain).

Farhad Islami MD PhD, Senior Scientific Director, Cancer Disparity Research, American Cancer Society, U.S.A

Farhad Islami received a MD degree from Tehran University of Medical Sciences, Iran, and a PhD in Epidemiology from King’s College London, United Kingdom. He worked as a postdoctoral fellow and scientist at the International Agency for Research on Cancer (Lyon, France) and as a faculty member at Icahn School of Medicine at Mount Sinai (New York) before joining the American Cancer Society in 2014, where he leads the Cancer Disparity Research team. His research focuses on quantifying the impact of factors that contribute to cancer disparities across the cancer continuum, including etiology, prevention, detection, treatment, and survivorship. He is the author or coauthor of more than 210 articles published in peer reviewed journals and several book chapters

Dr. Yu Ke, Research Fellow, Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore

Dr Yu Ke is a pharmacist by training who obtained her bachelor’s degree and PhD from the Department of Pharmacy, National University of Singapore. She is currently a research fellow at the Division of Supportive and Palliative Care, National Cancer Centre Singapore. Her research area lies in cancer supportive and survivorship care, with a particular interest in implementation science and health services research methodology. She has been working extensively with multidisciplinary healthcare professionals from tertiary and community settings and is an active member of the Multinational Association of Supportive Care in Cancer.

Jessica Keen, Pharmacy Lead, NHS NorthWest Genomic Medicines Service Alliance, U.K.

Jessica Keen is the Pharmacy Lead at the NHS NorthWest Genomic Medicines Service Alliance in the UK, working to embed genomic medicine into routine clinical pathways and ensure equity of access to genomic testing and treatments for patients.
She has recently completed an MSc in Genomic Medicine at the University of Manchester, with particular interest in the role of pharmacy teams and the wider workforce in the implementation of pharmacogenomics in the NHS. 
Her background is as an oncology pharmacist prescriber, specialising in Upper GI cancers and electronic prescribing. She is a member of the BOPA Genomics Special Interest Group.

Michael LeBlanc, Regional Manager of Clinical Pharmacy Services, Horizon Health Network, Moncton, Canada

Michael LeBlanc is the Regional Manager of Clinical Pharmacy Services for Horizon Health Network located in Moncton, New Brunswick, Canada where he is responsible for the development, evaluation and monitoring of clinical pharmacy services provided by over 250 pharmacists, technicians and assistants.  Prior to moving into his current position, Michael practiced as an oncology pharmacist for over 20 years in with a focus on the prevention and management of cancer-treatment associated toxicities. Michael remains active in direct patient care as a clinical resource pharmacist in oncology focusing on supporting patients receiving oral anti-cancer therapies.  In addition, he continues to conduct practice-based oncology and non-oncology pharmacy research with several publications and teaches undergraduate and post-graduate pharmacy students/learners. Michael is active in CAPhO, currently a member of the Research Committee, and the Canadian Society of Hospital Pharmacists where he is currently the chair of the Board of Trustees for the CSHP Foundation. In 2015 he was made a Fellow of the Canadian Society of Hospital Pharmacists.

Dr. Estela Moreno, Clinical Pharmacist, Hospital de la Santa Creu i Sant Pau,Barcelona, Spain

Estela Moreno graduated in 1998 in Pharmacy from University of Navarra. Completed her residency in hospital pharmacy at Hospital de la Santa Creu I San Pau in Barcelona in 2002 where she currently works as the leader of the oncology and hematology pharmaceutical care team and oncology and hematology clinical trials. 
She achieved Board Certification as an Oncology Pharmacist (BCOP) in 2005, a Research Sufficiency by University of Barcelona in 2008 and Master’s degree in cancer immunotherapy by University of Alcalá de Henares.
Estela is currently the National Coordinator of GEDEFO (Oncology Pharmacy Group of the Spanish Hospital Pharmacy Society), Chair of the Working Group Blood and Marrow transplantation of ESOP and Member of the Executive Committee of Pharmacists of the EBMT.
She is co-author in several publications, posters, oral communications related to oncology and hematology. Speaker and chair of various sessions at national and international conferences and postgraduate and master’s degrees. Estela is currently associate professor of Pharmacy degree at Blanquerna School of Health Sciences-Ramon Llull University in Barcelona 

Laura Álvarez Núñez, Clinical Pharmacist Resident, Pharmacy Service, Hospital General Universitario Dr. Balmis, Alicante, Spain

Laura Álvarez Núñez received her degree in Pharmacy from the University of Santiago de Compostela, in Spain. She completed a Master´s degree in Hospital Pharmacy in 2020 and started the residency in Hospital Pharmacy at the Hospital General Universitario Dr Balmis, in Alicante, where she is currently working. She has been growing as a pharmacist in a multidisciplinary environment along with other healthcare professionals, engaging with different areas such as oncology, hematology, clinical nutrition or galenics.

Shaun O'Connor, Senior Cancer Services Pharmacist, St Vincent’s Hospital Melbourne, Melbourne, Australia

Shaun is currently Senior Cancer Services Pharmacist at St Vincent’s Hospital Melbourne and Senior Project Officer, Cancer Support, Treatment and Research, Department of Health, Victoria. 
He is ISOPP's current Past-President, having also served as Treasurer and Standards Co-Chair. He is also Co-chair of the Society of Hospital Pharmacists of Australia Oncology/Hematology Specialty Practice Leadership Committee. He was the project manager for development and support of the VicTAG Chemotherapy Audit Toolkit and has been involved in organizing many ISOPP Australasian Symposia. 

Pau Riera Armengol, Clinical Pharmacist, Pharmacy Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Pau Riera has a degree in Chemistry and Pharmacy from the University of Barcelona. In 2011, Pau started the residency in Hospital Pharmacy at the Hospital de la Santa Creu i Sant Pau in Barcelona. At the end of the residency, Pau joined as a researcher predoctoral fellow at the Genetics Service of the same center, where he developed his doctoral thesis entitled "Genetic markers of efficacy and toxicity in the treatment of colorectal cancer", which was defended in September 2020. Since January 2021, Pau has been working as a clinical pharmacist and postdoctoral researcher at the Hospital de la Santa Creu i Sant Pau.

Arantza Vega Castro MD, PhD, Head of Allergy Department, Hospital University of Guadalajara, Guadalajara, Spain

Allergist, Head of the Allergy Department at the Hospital University of Guadalajara, Spain, and Associate Professor of allergy and clinical immunology in Medicine School of Universidad Internacional de Cataluña, Spain. 
Her interest areas are Hymenoptera venom allergy and drug desensitization in which she has been collaborating with different working teams in clinical research and guidelines. She is Scientific coordinator of the annual Drug Desensitization International Meeting (DDIM) since 2011, has been a speaker in national and international meetings and author of more than 35 international publications.

Jeryl J. Villadolid, PharmD, BCPS, BCOP, Wellness and Burnout Task Force Chair, Hematology/Oncology Pharmacy Association (HOPA), USA

Jeryl Villadolid, PharmD, BCPS, BCOP received her Doctor of Pharmacy from University of Florida and completed her pharmacy residencies at Atrium Health (PGY1) and Duke University Medical Center (PGY2). She was a Solid Tumor Clinical Specialist at University of Chicago Medicine and then became the lead Solid Tumor Clinical Pharmacist Coordinator at Levine Cancer Institute in 2014, specialized in Thoracic and Head/Neck Oncology. Jeryl joined Bristol Myers Squibb in 2021 as a Medical Science Liaison (MSL). She currently the Lung Point and Wellness Point for the MSL-Community Oncology team and the Chair of the Hematology/Oncology Pharmacy Association (HOPA) Wellness and Burnout Task Force. 

Dr. Irene Weru, Senior Specialist Pharmacist, Kenyatta National Hospital, Nairobi, Kenya

Irene is the head, pharmaceutical products at Kenyatta National Hospital and is responsible for formulary management, quantification, budgeting and supply chain planning. She has previously served as head of clinical pharmacy practice at the hospital. 
She is a member of the National Cancer Institute and Cancer Control Program of Kenya quality management and Treatment, Palliative Care and Survivorship expert working groups and contributed to the development of Guidelines for Establishment of Cancer Centres and National Cancer Protocols. Irene has been an ISOPP secretariat member since 2020 and is the current ISOPP secretary.
Irene has a Bachelor of Pharmacy degree (2001) and Master of Clinical Pharmacy (2009) both from the university of Nairobi. 

John Wiernikowski, PharmD, FISOPP, FCAPhO, McMaster University, Canada

John received his undergraduate Pharmacy degree from the University of Toronto and Doctorate from the State University of New York at Buffalo.  John’s practice is in Pediatric Haematology/Oncology at McMaster University in Canada and his research interests include clinical trials for Neuroblastoma, Cancer associated thrombosis, musculoskeletal complications of chemotherapy in children, and Clinical Practice Guideline development.  John also has a keen interest in Global health with a particular focus on equitable access to medicines in low and middle income countries.  John currently co-chairs the ISOPP Advocacy Committee.

Rukhsana Yusuf, Fulbright PhD Scholar, School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, Irvine, U.S.A 

Rukh Yusuf is Fulbright Scholar at University of California, Irvine. Rukh is  M.Phil. in Pharmacy and has Pharm D. degrees. She has worked as a clinical Pharmacist Pediatric Oncology and Bone Marrow transplant and also as Pharmacist total parenteral Nutrition. She has over eight years’ experience in Pharmacy Practice and over five years’ experience in Pharmaceutical Research. She has published manuscripts and abstracts in international and national journals. 

Some research articles are presently under publication process. She has received training for, and has experience in Pharmacy Practice, TPN, BMT, Research Projects and hands-on Training of Pharmacists and Doctors. She had a stint at the well-known 57357 cancer hospital, Egypt and she is currently working on multinational collaborative research.

Victoria Zapotochna, Business Coach, Chief Consultant, General Director of Tory Group, Kyiv, Ukraine

Victoria Zapotochna received the qualification of “Pharmacist” in the specialty “Pharmacy” at the National Medical University n.a. O.O. Bogomolets at the Ministry of Health of Ukraine, as well as a master’s degree at the Ukrainian Military Medical Academy at the Ministry of Defence of Ukraine, specializing in “Organization and Management of Pharmacy Economics.” Graduated from the EBA School of Negotiation.
International expert of Gerson Lehrman Group (New York, USA) and training Academy. Certified representative and member of ESOP and EUSOP, participant of the patient care international clinical pharmacy projects. Speaker and expert of the MBA course “Pharmaceutical Marketing” at the International Business School MIM Lyiv. Takes part as a speaker and lecturer at international conferences and exhibitions. 

Victoria has worked in various international companies for over 15 years, both in the production of medicines and sales and marketing.